BCL2 and B-cell chronic lymphocytic leukemia: This, together with our results of no correlation of bfl-1 or bcl-2 antiapoptotic gene expression with the mutational status, suggest that the difference in prognosis between B-CLL cases with unmutated or mutated IGHV genes is not explained by the cellular apoptosis sensitivity.